Publications:

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Molecular Cancer

Fang, Wenfeng W; Jin, Haoxuan H; Zhou, Huaqiang H; Hong, Shaodong S; Ma, Yuxiang Y; Zhang, Yaxiong Y; Su, Xiaofan X; Chen, Longyun L; Yang, Yunpeng Y; Xu, Shengqiang S; Liao, Yuwei Y; He, Yuming Y; Zhao, Hongyun H; Huang, Yan Y; Gao, Zhibo Z; Zhang, Li L

Publication Date: 2021-02-23

Variant appearance in text: CFTR: 2885C>A; S962Y

PubMed Link: 33622313

Variant Present in the following documents:

• 12943_2021_1331_MOESM3_ESM.xlsx, sheet 8

View BVdb publication page

Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation.

American Journal Of Physiology. Lung Cellular And Molecular Physiology

Arora, Kavisha K; Yarlagadda, Sunitha S; Zhang, Weiqiang W; Moon, ChangSuk C; Bouquet, Erin E; Srinivasan, Saumini S; Li, Chunying C; Stokes, Dennis C DC; Naren, Anjaparavanda P AP

Publication Date: 2016-08-01

Variant appearance in text: CFTR: 2885C>A

PubMed Link: 27261451

Variant Present in the following documents:

• Main text

View BVdb publication page